Healthcare -
Biotechnology - NASDAQ - US
$ 1.545
-2.83 %
$ 127 M
Market Cap
-1.0
P/E
Price Target
Average
676.70%
Revenue Forecast
Estimate
10.32%
EBIT
Estimate
--24.19%
Net Income
Estimate
--1.68%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Sutro Biopharma, Inc.
Wall Street analysts predict an average 1-year price target for STRO of $12 , with forecasts ranging from
a
low of
$8 to a high of $18 .
STRO Lowest Price Target
Wall Street Target
8 USD
417.80%
STRO Average Price Target
Wall Street Target
12 USD
676.70%
STRO Highest Price Target
Wall Street Target
18 USD
1065.05%
REVENUE FORECAST
Revenue Forecast Chart STRO
EBIT FORECAST
EBIT Forecast Chart STRO
NET INCOME FORECAST
Net Income Chart STRO